Literature DB >> 15706438

Role of gastrointestinal hormones in neuroblastoma.

W Clay Gustafson1, Brittany B De Berry, B Mark Evers, Dai H Chung.   

Abstract

As a neuroendocrine tumor, neuroblastoma expresses various gastrointestinal (GI) hormones, such as vasoactive intestinal peptide, gastrin-releasing peptide (GRP), neurotensin, and somatostatin, which exert diverse cellular functions in neuroblastoma. In particular, we have recently found that GRP and its cell surface receptor, GRP-R, are abundantly expressed in neuroblastomas. Moreover, more advanced-stage neuroblastomas demonstrated an increased level of GRP-R, suggesting an important role of GRP in aggressive tumor behavior. This review describes the role of several GI hormones commonly expressed in neuroblastoma and discusses in depth the mitogenic actions of GRP in neuroblastoma. In addition, the molecular mechanisms involved in the GRP-induced stimulation of neuroblastoma cell growth are discussed. Our study results demonstrate a role of GRP as an autocrine/paracrine growth factor and elucidate involvement of specific intracellular signaling, the phosphatidylinositol 3-kinase pathway, in the growth regulation of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706438     DOI: 10.1007/s00268-004-7815-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  62 in total

1.  Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas.

Authors:  J C Reubi; B Waser; J C Schaer; J A Laissue
Journal:  Int J Cancer       Date:  1999-07-19       Impact factor: 7.396

Review 2.  Oncological applications of somatostatin analogues.

Authors:  A V Schally
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

Review 3.  Endocrine gene neurotensin: molecular mechanisms and a model of intestinal differentiation.

Authors:  B Mark Evers
Journal:  World J Surg       Date:  2002-04-18       Impact factor: 3.352

4.  Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.

Authors:  Y Qin; T Ertl; R Z Cai; J E Horvàth; K Groot; A V Schally
Journal:  Int J Cancer       Date:  1995-10-09       Impact factor: 7.396

5.  Neuroblastoma. Correlation of neuropeptide expression in tumor tissue with other prognostic factors.

Authors:  S J Qualman; M S O'Dorisio; D J Fleshman; H Shimada; T M O'Dorisio
Journal:  Cancer       Date:  1992-10-01       Impact factor: 6.860

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer.

Authors:  Y Matsumori; N Katakami; M Ito; T Taniguchi; N Iwata; T Takaishi; K Chihara; T Matsui
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

8.  Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.

Authors:  M Koppán; G Halmos; J M Arencibia; N Lamharzi; A V Schally
Journal:  Cancer       Date:  1998-10-01       Impact factor: 6.860

9.  Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.

Authors:  M S O'Dorisio; D J Fleshman; S J Qualman; T M O'Dorisio
Journal:  Regul Pept       Date:  1992-02-18

10.  In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide.

Authors:  J C Pence; N A Shorter
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

View more
  12 in total

1.  Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells.

Authors:  Titilope A Ishola; JungHee Kang; Jingbo Qiao; B Mark Evers; Dai H Chung
Journal:  Biochim Biophys Acta       Date:  2007-02-20

2.  Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion.

Authors:  Sora Lee; Jingbo Qiao; Pritha Paul; Dai H Chung
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

3.  Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene.

Authors:  Radmila Santic; Katrin Fenninger; Kerstin Graf; Rainer Schneider; Cornelia Hauser-Kronberger; Freimut H Schilling; Per Kogner; Manfred Ratschek; Neil Jones; Wolfgang Sperl; Barbara Kofler
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Bombesin induces angiogenesis and neuroblastoma growth.

Authors:  Junghee Kang; Titilope A Ishola; Naira Baregamian; Joshua M Mourot; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2007-03-26       Impact factor: 8.679

Review 5.  Pharmacologic management of high-risk neuroblastoma in children.

Authors:  Veena R Ganeshan; Nina F Schor
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

6.  Synthesis, characterization, and evaluation of a novel 99mTc(CO)3 pyrazolyl conjugate of a peptide nucleic acid sequence.

Authors:  Catarina Xavier; Clelia Giannini; Sergio Dall'Angelo; Lurdes Gano; Stefano Maiorana; Roger Alberto; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2008-09-06       Impact factor: 3.358

7.  Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.

Authors:  Jingbo Qiao; Junghee Kang; Titilope A Ishola; Piotr G Rychahou; B Mark Evers; Dai H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

8.  Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells.

Authors:  Jens Bedke; Bernhard Hemmerlein; Christina Perske; Andreas Gross; Markus Heuser
Journal:  World J Urol       Date:  2009-12-13       Impact factor: 4.226

9.  Akt2 regulates metastatic potential in neuroblastoma.

Authors:  Jingbo Qiao; Sora Lee; Pritha Paul; Lan Qiao; Chase J Taylor; Cameron Schlegel; Nadja C Colon; Dai H Chung
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

10.  Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.

Authors:  Pritha Paul; Jingbo Qiao; Kwang Woon Kim; Carmelle Romain; Sora Lee; Natasha Volny; Bret Mobley; Hernan Correa; Dai H Chung
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.